Published in Biorheology on January 01, 2010
Autoregulation and mechanotransduction control the arteriolar response to small changes in hematocrit. Am J Physiol Heart Circ Physiol (2012) 0.83
Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expander. Life Sci (2011) 0.78
Response of cardiac endothelial nitric oxide synthase to plasma viscosity modulation in acute isovolemic hemodilution. Asian J Transfus Sci (2014) 0.75
How to randomise. BMJ (1999) 5.24
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc (2008) 4.50
Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation (1984) 2.57
In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol (1998) 2.22
Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol (1979) 1.73
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol (2004) 1.67
Direct comparison of magnetic resonance imaging and conductance microcatheter in the evaluation of left ventricular function in mice. Basic Res Cardiol (2005) 1.60
Microvascular pressure and functional capillary density in extreme hemodilution with low- and high-viscosity dextran and a low-viscosity Hb-based O2 carrier. Am J Physiol Heart Circ Physiol (2004) 1.53
Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol (2004) 1.52
Paradoxical hypotension following increased hematocrit and blood viscosity. Am J Physiol Heart Circ Physiol (2005) 1.35
Preferable anesthetic conditions for echocardiographic determination of murine cardiac function. J Pharmacol Sci (2005) 1.24
Shear stress induces eNOS mRNA expression and improves endothelium-dependent dilation in senescent soleus muscle feed arteries. J Appl Physiol (1985) (2004) 1.17
Efficiency of energy transfer from pressure-volume area to external mechanical work increases with contractile state and decreases with afterload in the left ventricle of the anesthetized closed-chest dog. Circulation (1988) 1.05
Nitric oxide generation by endothelial cells exposed to shear stress in glass tubes perfused with red blood cell suspensions: role of aggregation. Am J Physiol Heart Circ Physiol (2008) 1.01
Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution. Am J Physiol Heart Circ Physiol (2004) 0.95
Blood viscosity maintains microvascular conditions during normovolemic anemia independent of blood oxygen-carrying capacity. Am J Physiol Heart Circ Physiol (2006) 0.94
Equal oxygen consumption rates of isovolumic and ejecting contractions with equal systolic pressure-volume areas in canine left ventricle. Circ Res (1981) 0.94
Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species. Chem Pharm Bull (Tokyo) (1968) 0.92
Cardiovascular and metabolic response to acute normovolemic anemia. Effects of anesthesia. Anesthesiology (2000) 0.92
Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats. Am J Physiol Heart Circ Physiol (2007) 0.91
Microvascular benefits of increasing plasma viscosity and maintaining blood viscosity: counterintuitive experimental findings. Biorheology (2009) 0.90
Beneficial effects due to increasing blood and plasma viscosity. Clin Hemorheol Microcirc (2006) 0.87
Anesthesia alters the pattern of aerosol retention in hamsters. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.86
Evaluation of the clinical usefulness of thermodilution volumetric catheters. Crit Care Med (1995) 0.84
Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia. Am J Physiol (1969) 0.84
Higher viscosity participates in the regulation of coronary flow via nitric oxide and indomethacin-sensitive contracting factor. Can J Physiol Pharmacol (2004) 0.82
Does colloid-induced plasma hyperviscosity in haemodilution jeopardize perfusion and oxygenation of vital organs? Acta Anaesthesiol Scand (1995) 0.81
Effects of propranolol on myocardial performance during acute normovolemic hemodilution. J Cardiothorac Vasc Anesth (1991) 0.81
Breathing and lung mechanics in hamsters: effect of pentobarbital anesthesia. J Appl Physiol (1985) (1990) 0.81
Myocardial blood flow and oxygen consumption during isovolemic hemodilution alone and in combination with adenosine-induced controlled hypotension. Anesth Analg (1988) 0.81
Interaction between phencyclidine and pentobarbital in several species of laboratory animals. Commun Psychopharmacol (1978) 0.79
Left ventricular dimensions during hemorrhagic shock measured by biplane cinefluorography. Am J Physiol (1992) 0.79
Characteristics of ventricular function in severe hemorrhagic shock. Surgery (1983) 0.79
Hypovolemic shock and cardiac contractility: assessment by end-systolic pressure-volume relations. Res Exp Med (Berl) (1996) 0.79
Nitric oxide synthase inhibition reduces venous return in porcine endotoxemia. Am J Physiol (1996) 0.78
Acute normovolaemic haemodilution beyond a haematocrit of 25%: ratio of skeletal muscle tissue oxygen tension and cardiac index is not maintained in the healthy dog. Eur J Anaesthesiol (2002) 0.78
Effects of dextran-induced hyperviscosity on regional blood flow and hemodynamics in dogs. Am J Physiol (1989) 0.78
Cardiovascular effects of acute normovolemic hemodilution in rats with disopyramide-induced myocardial depression. Basic Res Cardiol (1990) 0.76
Evidence for constitutive release of nitric oxide in the venous circuit of pigs. J Cardiovasc Pharmacol (1998) 0.76
Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol (2009) 2.29
Lowering of blood pressure by increasing hematocrit with non nitric oxide scavenging red blood cells. Am J Respir Cell Mol Biol (2007) 1.70
Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion (2004) 1.59
Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am J Physiol Heart Circ Physiol (2004) 1.52
Microvascular and systemic effects following top load administration of saturated carbon monoxide-saline solution. Crit Care Med (2007) 1.51
Effects of fibrinogen concentrate after shock/resuscitation: a comparison between in vivo microvascular clot formation and thromboelastometry*. Crit Care Med (2013) 1.40
Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood (2006) 1.32
Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia. Am J Physiol Heart Circ Physiol (2003) 1.19
Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence. Transfus Apher Sci (2010) 1.07
Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J Neuroinflammation (2011) 1.04
Microcirculatory changes during chronic adaptation to hypoxia. Am J Physiol Heart Circ Physiol (2003) 0.98
Blood pressure directly correlates with blood viscosity in diabetes type 1 children but not in normals. Clin Hemorheol Microcirc (2010) 0.97
Survival time in severe hemorrhagic shock after perioperative hemodilution is longer with PEG-conjugated human serum albumin than with HES 130/0.4: a microvascular perspective. Crit Care (2008) 0.97
Oxygen release from low and normal P50 Hb vesicles in transiently occluded arterioles of the hamster window model. Am J Physiol Heart Circ Physiol (2005) 0.96
Increased cardiac output and microvascular blood flow during mild hemoconcentration in hamster window model. Am J Physiol Heart Circ Physiol (2006) 0.95
Microcirculatory effects of changing blood hemoglobin oxygen affinity during hemorrhagic shock resuscitation in an experimental model. Shock (2009) 0.94
Nitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malaria. PLoS Pathog (2013) 0.93
Resuscitation from hemorrhagic shock with MalPEG-albumin: comparison with MalPEG-hemoglobin. Shock (2004) 0.92
Radial displacement of red blood cells during hemodilution and the effect on arteriolar oxygen profile. Am J Physiol Heart Circ Physiol (2003) 0.92
Microhemodynamic aberrations created by transfusion of stored blood. Transfusion (2013) 0.92
S-nitrosoglutathione prevents experimental cerebral malaria. J Neuroimmune Pharmacol (2012) 0.91
Exogenous nitric oxide prevents cardiovascular collapse during hemorrhagic shock. Resuscitation (2011) 0.91
Effect of oxygen consumption by measuring method on PO2 transients associated with the passage of erythrocytes in capillaries of rat mesentery. Am J Physiol Heart Circ Physiol (2005) 0.91
Microvascular effects following treatment with polyethylene glycol-albumin in lipopolysaccharide-induced endotoxemia. Crit Care Med (2006) 0.89
Integration of cardiovascular regulation by the blood/endothelium cell-free layer. Wiley Interdiscip Rev Syst Biol Med (2011) 0.88
The variability of blood pressure due to small changes of hematocrit. Am J Physiol Heart Circ Physiol (2010) 0.86
Microlymphatic and tissue oxygen tension in the rat mesentery. Am J Physiol Heart Circ Physiol (2003) 0.86
Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Acta (2008) 0.84
PEG-albumin supraplasma expansion is due to increased vessel wall shear stress induced by blood viscosity shear thinning. Am J Physiol Heart Circ Physiol (2012) 0.84
Plasma expander viscosity effects on red cell-free layer thickness after moderate hemodilution. Biorheology (2011) 0.84
Oxygen distribution and respiration by the microcirculation. Antioxid Redox Signal (2004) 0.84
Synthesis and biophysical properties of polymerized human serum albumin. Biotechnol Prog (2011) 0.84
Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins. Biomaterials (2010) 0.83
The vascular wall as a regulator of tissue oxygenation. Curr Opin Nephrol Hypertens (2006) 0.83
Autoregulation and mechanotransduction control the arteriolar response to small changes in hematocrit. Am J Physiol Heart Circ Physiol (2012) 0.83
Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med (2014) 0.83
Excessive erythrocytosis does not elevate capillary oxygen delivery in subcutaneous mouse tissue. Microcirculation (2007) 0.83
Hematocrit and mean arterial blood pressure in pre- and postmenopause women. Vasc Health Risk Manag (2009) 0.82
Can the effects of vasoactivity of molecular hemoglobin-based plasma expanders be ignored? Crit Care Med (2006) 0.82
Microvascular perspective of oxygen-carrying and -noncarrying blood substitutes. Annu Rev Biomed Eng (2006) 0.82
Effects of plasma viscosity modulation on cardiac function during moderate hemodilution. Asian J Transfus Sci (2010) 0.82
A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response. Nitric Oxide (2012) 0.81
Small-volume resuscitation from hemorrhagic shock with polymerized human serum albumin. Am J Emerg Med (2011) 0.81
Hypervolemic infusion of Lumbricus terrestris erythrocruorin purified by tangential-flow filtration. Transfusion (2012) 0.81
Blood viscosity: a factor in tissue survival? Crit Care Med (2005) 0.81
Increased hematocrit and reduced blood pressure following control of glycemia in diabetes. Clin Hemorheol Microcirc (2008) 0.81
Synthesis, biophysical properties, and oxygenation potential of variable molecular weight glutaraldehyde-polymerized bovine hemoglobins with low and high oxygen affinity. Biotechnol Prog (2011) 0.80
New phosphorescence quenching oxygen measurements technique yields unusual tissue and plasma PO2 distributions. J Appl Physiol (1985) (2007) 0.80
Oxygen delivery during extreme anemia with ultra-pure earthworm hemoglobin. Life Sci (2012) 0.80
Increased hemoglobin O2 affinity protects during acute hypoxia. Am J Physiol Heart Circ Physiol (2012) 0.80
Transport of nitric oxide by perfluorocarbon emulsion. Biotechnol Prog (2013) 0.79
Hexa-thiocarbamoyl phenyl PEG5K Hb: vasoactivity and structure: influence of rigidity of the conjugation linkage on the PEGylation induced plasma expander-like solution properties of PEG-Hb adducts. Protein J (2009) 0.79
Nonlinear cardiovascular regulation consequent to changes in blood viscosity. Clin Hemorheol Microcirc (2011) 0.79
Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expander. Life Sci (2011) 0.78
Terminal lymphatics: the potential "lethal corner" in the distribution of tissue pO2. Lymphat Res Biol (2007) 0.78
Oxygen-carrying blood substitutes: a microvascular perspective. Expert Opin Biol Ther (2004) 0.78
Effect of deformability difference between two erythrocytes on their aggregation. Phys Biol (2013) 0.77
Improved resuscitation from hemorrhagic shock with Ringer's lactate with increased viscosity in the hamster window chamber model. J Trauma (2011) 0.77
The physics of oxygen delivery: facts and controversies. Antioxid Redox Signal (2010) 0.77
Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO production. Biophys Chem (2012) 0.77
Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states. Tissue Eng Part A (2011) 0.77
Microhemodynamic parameters quantification from intravital microscopy videos. Physiol Meas (2014) 0.77
Hemorheological implications of perfluorocarbon based oxygen carrier interaction with colloid plasma expanders and blood. Biotechnol Prog (2013) 0.77
Small-volume resuscitation from hemorrhagic shock using high-molecular-weight tense-state polymerized hemoglobins. J Trauma (2011) 0.77
Improving cardiac function with new-generation plasma volume expanders. Am J Emerg Med (2012) 0.76
Cardiac systolic function recovery after hemorrhage determines survivability during shock. J Trauma (2011) 0.76
Microvascular oxygen delivery and consumption following treatment with verapamil. Am J Physiol Heart Circ Physiol (2004) 0.76
Localized increase of tissue oxygen tension by magnetic targeted drug delivery. Nanotechnology (2014) 0.76
Oxygen transport during hemodilution with a perfluorocarbon-based oxygen carrier: effect of altitude and hyperoxia. J Appl Physiol (1985) (2008) 0.76
Posttransfusion Increase of Hematocrit per se Does Not Improve Circulatory Oxygen Delivery due to Increased Blood Viscosity. Anesth Analg (2017) 0.76
Nanoengineering bactericidal nitric oxide therapies. Virulence (2011) 0.75
Effects of acute anemia and hyperoxia on oxygen distribution. Adv Exp Med Biol (2012) 0.75
Nonobese, exercising children diagnosed with dyslipidemia have normal C-reactive protein. Vasc Health Risk Manag (2009) 0.75
Will fixing the vasoactivity caused by hemoglobin-based oxygen carriers be enough? Crit Care Med (2009) 0.75
Plasma expander and blood storage effects on capillary perfusion in transfusion after hemorrhage. Transfusion (2012) 0.75
Two-phase model for prediction of cell-free layer width in blood flow. Microvasc Res (2012) 0.75
Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia. Artif Cells Nanomed Biotechnol (2014) 0.75
Blood Quality Diagnostic Device Detects Storage Differences Between Donors. IEEE Trans Biomed Circuits Syst (2017) 0.75
Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report. Oncol Res Treat (2016) 0.75